Skip to main content
Enter your keywords
User account menu
Log in
Main navigation
About
History & Impact
Mission & Values
Leadership
Support SWOG
Join SWOG
Policies & Procedures
Careers
Contact Us
The SWOG Network
How We Work
Our Staff
Our Advocates
Our Partners
News & Events
News
SWOG Meetings
For Press
Clinical Trials
Biospecimen Submission
Biospecimen Access
Data Requests
Clinical Trials Search
Clinical Research Resources
Frequently Asked Questions
Publications
Institutions
Quality Assurance & Audits
Serious Adverse Events
Training Resources
ORP (CRA) Workbench
Protocol Workbench
Workbenches
ORP (CRA) Workbench
Protocol Workbench
VA Workbench
For Patients
Patient & Advocate Voices
Trials Open to Patients
About SWOG Cancer Trials
Joining a Trial
Section navigation
Recent Updates
12/1/2025
11/15/2025
11/1/2025
10/15/2025
10/1/2025
9/15/2025
9/1/2025
8/15/2025
8/1/2025
7/15/2025
7/1/2025
6/15/2025
All Updates
Breadcrumb
SWOG
Member Resources
Trial & Business Updates
Head and Neck Cancer
Priority List Head and Neck Cancer
S2101
II
Biomarker Stratified CaboZantinib and NivOlumab (BiCaZO) - A phase II study of combining cabozantinib and nivolumab in patients with advanced solid tumors stratified by tumor biomarkers
21CTP.HN01
II
Phase II Study of Amivantamab carboPlatin and pacliTaxel in recurrent metastatic Head and Neck cancer (CAPT-HN) Study Synopsis
